Business Wire

Clinical Data on Lumicell’s Direct Visualization System to Be Presented at International Conference on Surgical Cancer Care

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that clinical data from a ...
Business Wire

Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug ...
KHON2

Lumicell Granted Permanent HCPCS Code for Intraoperative Fluorescence Imaging Margin Assessment

Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...
tapinto.net

Hunterdon Medical Center and The Institute for Advanced Reconstruction Become the First on the East Coast to Implement Lumicell® Precision Guided Breast Cancer Surgery

Hunterdon Medical Center and The Institute for Advanced Reconstruction proudly announce being the first healthcare providers on the East Coast to use the Lumicell® Direct Visualization System for ...
Medscape

Novel Fluorescence Guidance Improves Lumpectomy Outcomes

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...
BioWorld

Lumicell shines a light on residual breast cancer with FDA approvals

Lumicell Inc. sees a brighter future now that it has secured U.S. FDA approval for both its new drug application for Lumisight (pegulicianine) optical imaging agent and premarket approval for the ...
abc27

Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy

NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the U.S. commercial ...